Oxford Instruments appoints Gavin Hill as group FD

Provider of high-technology tools and systems Oxford Instruments announced the appointment of Gavin Hill as group finance director effective from 9 May following the resignation of Kevin Boyd.

Hill was group FD of Synergy Health from April 2010 until the merger with Steris Corp in November and is currently assisting with the integration of the two companies.

Prior to that, he was corporate finance director of Serco, where he held a number of senior finance and commercial positions, and held a variety of roles in finance and corporate treasury with Syngenta and AstraZeneca.

Chairman Nigel Keen said: “He brings excellent financial and listed company credentials, which will make a significant contribution to the future growth of the business and to the board.”

The company announced in October that Kevin Boyd would be stepping down as group FD to take up the same role at Spirax-Sarco Engineering in April.

At 1040 GMT, Oxford shares were up 2.6% to 685p.